Special Issue "Skull Base Surgery for Tumour and Vascular Lesions in 2022 and Beyond"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".

Deadline for manuscript submissions: 20 June 2023 | Viewed by 495

Special Issue Editors

Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan
Interests: skull base surgery; meningioma; vestibular schwannoma; craniopharyngioma; complicated cerebrovascular disease; microvascular decompression
Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
Interests: skull base surgery; neuroendoscopic surgery; benign brain neoplasms; cerebrovascular surgery; radiosurgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Various neoplastic and vascular pathologies can arise in the skull base, and such lesions are generally intractable due to the deep location and the proximity to critical neurovascular structures. Following decades of selfless effort by forerunners, we have observed many developments in open skull base surgical approaches in the late twentieth century. Excellent long-term outcomes have become more and more achievable thanks to an improved understanding of skull base anatomies, modern vascular and skull base reconstruction techniques, endovascular treatment, and stereotactic radiosurgery used either adjunctively or solely. Furthermore, endoscopic and exoscopic surgeries have taken a leading role in some skull base surgeries. With these multi-disciplinary therapeutic options, the paradigm has now begun to shift from “destructive” toward “minimally invasive,” aiming not only to “control lesions” but also to “preserve function”. In this Special Issue, a diversity of contributions from not only neurosurgeons but also otorhinolaryngologists, plastic surgeons, radiation oncologists, and endovascular surgeons are welcomed.

Prof. Dr. Soichi Oya
Dr. Hirotaka Hasegawa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • skull base surgery
  • microsurgery
  • endoscope
  • exoscope
  • cerebrovascular disease
  • skull base reconstruction
  • function-al preservation
  • transsphenoidal surgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Effects of Craniotomy and Endoscopic Endonasal Transsphenoidal Surgery on Bodyweight in Adult-Onset Craniopharyngioma: A Single-Center Retrospective Study
J. Clin. Med. 2023, 12(4), 1578; https://doi.org/10.3390/jcm12041578 - 16 Feb 2023
Viewed by 310
Abstract
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although surgical treatment is essential in managing CP, the best surgical approach is debated. A retrospective cohort of 117 patients with adult-onset CP (AOCP) treated between 2018 and 2020 in Beijing [...] Read more.
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although surgical treatment is essential in managing CP, the best surgical approach is debated. A retrospective cohort of 117 patients with adult-onset CP (AOCP) treated between 2018 and 2020 in Beijing Tiantan Hospital was identified and examined. The effects of traditional craniotomy (TC) and endoscopic endonasal transsphenoidal surgery (EETS) on the extent of surgical resection, hypothalamic involvement (HI), postoperative endocrine function, and postoperative weight were compared in the cohort. The cohort comprised 43 males and 74 females, divided into the TC (n = 59) and EETS (n = 58) groups. The EETS group possessed a higher rate of gross total resection (GTR) (adjusted odds ratio (aOR) = 4.08, p = 0.029) and improved HI (aOR = 2.58, p = 0.041) than the TC group. Worse postoperative HI was only observed in the TC group (5 patients). The EETS was associated with fewer adverse hormonal outcomes, including posterior pituitary dysfunction (aOR = 0.386, p = 0.040) and hypopituitarism (aOR = 0.384, p = 0.031). Additionally, multivariate logistic regression analysis confirmed that EETS was related to fewer cases of weight gain >5% (aOR = 0.376, p = 0.034), significant weight change (aOR = 0.379, p = 0.022), and postoperative obesity (aOR = 0.259, p = 0.032). Compared to TC, EETS shows advantages in accomplishing GTR, hypothalamus protection, postoperative endocrine function reservation, and postoperative weight control. These data suggest that the EETS deserves more application in managing patients with AOCP. Full article
(This article belongs to the Special Issue Skull Base Surgery for Tumour and Vascular Lesions in 2022 and Beyond)
Show Figures

Figure 1

Back to TopTop